20/20 Biolabs is trading 5.27% up at $0.66 in after-hours trading after closing at $0.62 on August 28, 2026, with no clear catalyst identified.
- The September 2 investor webinar was rescheduled to 2:00 p.m. Eastern time.
- Management will discuss second-quarter results and commercial progress.
- Recent gains continued, while broader markets were mixed and offered no clear explanation.